Table 1 The role of microRNAs in cancers microRNAsTumorigenesis miR-9Neuroblastoma miR-10bBreast cancer miR-15, miR-15aLeukemia, pituitary adenoma.

Slides:

Advertisements

Similar presentations

INTEGRATED ANALYSIS OF THE MOLECULAR DEREGULATIONS OF THE MDM2:P53 AXIS IN DDLPS KATE LYNN BILL, JEANNINE GARNETT, CHAD CREIGHTON, XIAOYAN MA, ISABELLE.

Advertisements

Table 1 The role of microRNAs in cancers microRNAsTumorigenesis miR-9Neuroblastoma miR-10bBreast cancer miR-15, miR-15aLeukemia, pituitary.

Somatic Mutation Distributions Determining Cut-offs Supp. Figure 5.

Targil – Signal transduction.

Reporting on Scientific Journal Articles Jeremy Moore, M.A. Senior Manager, Science Communications American Association for Cancer Research

Progress on Biomarkers of Cancer Diagnosis and Prognosis

Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness Gary Xiao, Ph.D. Professor and Director School of Pharmaceutical Science & Technology.

Advanced Cancer Topics Journal Review 4/16/2009 AD.

Ann E. Rougvie Nature Reviews Genetics 2, (September 2001)

An Introduction to Nervous Systems © 2007 by Cold Spring Harbor Laboratory Press. Chapter 8, Figure 1.

Causes and consequences of microRNA dysregulation in cancer

University of São Paulo - Brazil Laboratory of Medical Investigation – Urology Antagonism between miR-21 and 338-3p in prostate cancer invasion through.

Therapeutic miRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model Janaiah Kota,1 Raghu R. Chivukula,2 Kathryn A. O’Donnell,3,4 Erik A.

Figure 1 Cell , DOI: ( /S (04) )

Growth Factors, Receptors,

From a to α Yeast as a Model for Cellular Differentiation © 2007 by Cold Spring Harbor Laboratory Press. Chapter 3, Figure 1.

FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,

In describing a person’s cancer what would T2 mean? In describing a person’s cancer what does M1 mean? In describing a person’s cancer what does N0 mean?

Karli Has Cancer Group Discussion 1.In what ways is Karli different from you? 2.What does Karli mean when she says people “don’t understand that cancer.

PIK3CA gene amplification in glioblastoma and squamous cell carcinoma (SCC) of the lung. PIK3CA gene amplification in glioblastoma and squamous cell carcinoma.

Immune Keytruda.

Wijendra Senarathne1, Peggy Gates1, Semir Vranic2, Zoran Gatalica1

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.

Andrew Fire, SiQun Xu, Mary K. Montgomery, Steven A. Kostas, Samuel E

Table 1. Scientific findings of previously published work on Graviola

Glioblastoma Multiforme SSEA1+ CD133+

Inflammation and Cancer: IL-6 and STAT3 Complete the Link

Incidence of nonskin cancers at five years

IL-22 Gets to the Stem of Colorectal Cancer

Andrea L Kasinski, Frank J Slack Molecular Therapy - Nucleic Acids

Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension

Van’t Veer et al, Nature 415: (2002)

Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma

ML criticality in clinical outcome across cancer types.

Hotspot mutations drive clustering of tumor types

Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21

Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.

Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma

Eun-Jung Jung, George A. Calin Cancer Cell

MicroRNA Regulation of Stem Cell Fate

MicroRNAs and Parallel Stem Cell Lives

Kelsie L. Thu, BSc, Raj Chari, PhD, William W

Expression of NCoR1∆ID in PAX8−/− mice does not reverse repression of T3-positive target genes. qPCR on the indicated pituitary (A) and neuronal (B) genes.

Cellular Pliancy and the Multistep Process of Tumorigenesis

Molecular Prophets of Death in the Fly

Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?

The Mucinous Lung Tumor Signature is highly enriched in colorectal, stomach, pancreatic, lung (adenocarcinoma; LUAD), and breast cancers The Mucinous Lung.

IMITAB® (Imatinib Mesylate BP Tablets)

Proposed model of how USP2a-driven microRNA deregulation enhances MYC protein expression through impairment of the MDM2–p53 pathway. p53 regulates miR-34b/c.

Canonical gliomagenesis mediators EGFR, P53, and retinoblastoma protein (RB1) are important for cancer signaling. Canonical gliomagenesis mediators EGFR,

Proposed model of the tumor-suppressive effects of TPL2 in the lung.

Hypothetical model of HvAP2 control of stem elongation.

Marta Chesi, P. Leif Bergsagel Cancer Cell

PTENP1 serves as a ceRNA in the regulation of tumor growth in RCC

A, PTEN loss signature score in resected SQCLC brain metastases.

MPGES is expressed in epithelial cells in benign and malignant tumors of the colon. mPGES is expressed in epithelial cells in benign and malignant tumors.

Cytofluorometry analysis demonstrating the specific coating of anti-tumor Fab-HLA-A2/Flu conjugates on the surface of HLA-A2 negative tumor target cells,

Antitumor effects of celastrol in vitro and in vivo.

Figure 3. Immunohistochemistry assay for Mfn2 in each group

miR-100 suppresses bladder cancer cell growth in vitro and in vivo.

Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.

The critical roles of miR-23a and miR-27a in colorectal cancer progression. miR-23a primarily increases cell motility through downregulation of its target.

Cell-autonomous mechanisms of resistance to targeted therapies involving the HGF/MET axis. Cell-autonomous mechanisms of resistance to targeted therapies.

mRNA expression of PARP1 in SCLC cell lines and solid tumors.

FGFR2 amplification in gastric and colon cancer cell lines is associated with response to NVP-BGJ398. FGFR2 amplification in gastric and colon cancer cell.

Receiver operating curve for faecal calprotectin in detecting patients with colorectal neoplasia (carcinoma and adenoma). Receiver operating curve for.

Presentation transcript:

Table 1 The role of microRNAs in cancers microRNAsTumorigenesis miR-9Neuroblastoma miR-10bBreast cancer miR-15, miR-15aLeukemia, pituitary adenoma miR-16, miR-16-1Leukemia, pituitary adenoma miR-17-5p, miR-17-92Lung cancer, lymphoma miR-20aLymphoma, lung cancer miR-21Breast cancer, cholangiocarcinoma, head & neck cancer, leukemia, cervical cancer, Pancreatic cancer miR-29, miR-29bLeukemia, cholangiocarcinoma miR-31Colorectal cancer miR-34aPancreatic cancer, Neuroblastoma miR-96Colorectal cancer miR-98Head & neck cancer miR-103Pancreatic cancer miR-107Leukemia, pancreatic cancer miR-125a, miR-125bNeuroblastoma, breast cancer miR-128Glioblastoma miR-133bColorectal cancer miR-135bColorectal cancer miR-143Colon cancer, cervical cancer miR-145Breast cancer, colorectal cancer miR-146Thyroid carcinoma miR-155Breast cancer, leukemia, pancreatic cancer miR-181, miR-181a, miR-181cLeukemia, glioblastoma, thyroid carcinoma miR-183Colorectal cancer miR-184Neuroblastoma miR-196a-2Pancreatic cancer miR-221Glioblastoma, thyroid carcinoma, Pancreatic cancer miR-222Thyroid carcinoma miR-223Leukemia miR-301Pancreatic cancer miR-376Pancreatic cancer let-7, let-7a, let-7a-1, let-7a-3Lung cancer, colon cancer Mol Cancer. 2007; 6: 60. Published online 2007 September 25. doi: / Copyright © 2007 Cho; licensee BioMed Central Ltd.

Let-7g impairs proliferation and enhances cell death. Kumar M S et al. PNAS 2008;105: ©2008 by National Academy of Sciences

Let-7g-induced tumors maintain overexpression and target suppression. Kumar M S et al. PNAS 2008;105: ©2008 by National Academy of Sciences

Let-7g suppresses tumorigenesis in vivo. Kumar M S et al. PNAS 2008;105: ©2008 by National Academy of Sciences

K-RasG12D substantially rescues let-7g-mediated tumor suppression. Kumar M S et al. PNAS 2008;105: ©2008 by National Academy of Sciences

Let-7g suppresses tumor initiation in an autochthonous NSCLC model. Kumar M S et al. PNAS 2008;105: ©2008 by National Academy of Sciences

miR-26a is amplified in glioma. Huse J T et al. Genes Dev. 2009;23: ©2009 by Cold Spring Harbor Laboratory Press

miR-26a-expressing murine gliomas (P/26a). Huse J T et al. Genes Dev. 2009;23: ©2009 by Cold Spring Harbor Laboratory Press

miR-26a facilitates gliomagenesis in vivo. Huse J T et al. Genes Dev. 2009;23: ©2009 by Cold Spring Harbor Laboratory Press

miR-26a represses PTEN expression in murine gliomas. Huse J T et al. Genes Dev. 2009;23: ©2009 by Cold Spring Harbor Laboratory Press